Corporate advisor Ed Lukins has joined Orrick as a partner based in London. He joins from Cooley, where he helped found the London office.
Lukins focuses on the life sciences, tech and oil & gas and natural resource sectors, providing advice to public and pre-IPO private companies, private equity houses, entrepreneurs and banks in connection with domestic and cross-border capital markets and M&A transactions, strategic ventures and other corporate matters. He counsels companies and their advisors through all stages of the corporate life cycle, including financings, exits, public to privates and institutional buyouts.
His IPO practice has most recently included the US listings of UK-based companies Endava (DAVA) and Autolus Therapeutics (AUTL), as well as serving as underwriters’ counsel for the IPOs of Atlassian (TEAM) and Bicycle Therapeutics (BCYC). Ed has also advised on a number of AIM and UK Main Market IPOs, including RenalytixAI plc and OKYO Pharma Limited. In the oil & gas sector, Ed recently acted for RockRose Energy plc on a reverse takeover involving the acquisition of the North Sea interests of US-based Marathon.
“Ed is a highly respected senior corporate advisor whom I’ve known and admired for years, and I’m thrilled he’s joining our London team. His practice is a strategic addition as we focus on advising Tech, Life Science and Energy companies globally,” says Chris Grew, head of Orrick’s No1 ranked European Venture Capital practice (Pitchbook).
“Orrick’s platform is a real draw: the firm’s focus on the sectors driving the global economy, its emphasis on building top tier sector-focused practices to support its corporate offering, its collaborative and global approach and its leadership in innovative service delivery are all aligned with where client demand will be in the future,” noted Ed. “I look forward to working with Chris and the London team to build on this platform.”
“Ed’s addition is an exciting step in our London growth strategy,” adds Simon Willis, Orrick’s London Office Leader. “He brings a practice and team approach that is a perfect fit with our strategy and will be valuable both in serving our clients and connecting the firm globally.”
